86
Participants
Start Date
September 1, 2017
Primary Completion Date
September 30, 2017
Study Completion Date
December 29, 2017
Intramuscular ZENEO® injection of nominal strength
Sodium Chloride (0.9%)
Intramuscular ZENEO® injection of low strength (upper limit)
Sodium Chloride (0.9%)
Intramuscular ZENEO® injection of low strength (lower limit)
Sodium Chloride (0.9%)
Lead Sponsor
Crossject
INDUSTRY